Next generation therapeutics for Alzheimer's disease
Abstract To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic ill...
Autors principals: | Dale E. Bredesen, Varghese John |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
Springer Nature
2013-05-01
|
Col·lecció: | EMBO Molecular Medicine |
Matèries: | |
Accés en línia: | https://doi.org/10.1002/emmm.201202307 |
Ítems similars
-
Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
per: Joaquin Abelli, et al.
Publicat: (2022-12-01) -
Emerging advances in fluorescence imaging and phototherapy of arthritis
per: Xiaoxuan Wang, et al.
Publicat: (2023-11-01) -
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
per: María Gabriela Montiel Schneider, et al.
Publicat: (2022-01-01) -
Editorial: Highlights in Alzheimer's and Parkinson's disease
per: Mariagiovanna Cantone, et al.
Publicat: (2023-08-01) -
Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD)
per: Talip Yiğit, et al.
Publicat: (2024-03-01)